Welcome to PERFORM

In the next five years, PERFORM will develop a comprehensive management plan for febrile patients, capable of being implemented across different health-care systems in Europe, linking sophisticated new genomic and proteomic approaches to clinical phenotyping.

COVID-19 - From New Challenges to New Solutions

7 May 2020

Photo by Tim Rouen
The PERFORM consortium are optimistic their novel diagnostic approaches can accelerate the understanding of COVID-19. It has been a trying time, many aspects of our lives have changed and as we move towards an endzone, the rhetoric of ‘back to normal’ seems more likely to be a normal, version 2.0. Many research projects, especially those involving clinical research, have been abruptly stopped in their tracks by COVID-19. However the consortia of PERFORM and its cousin EU-funded project, DIAMONDS (commenced January 2020) have rapidly adapted to apply their expertise to tackling this new virus.

Why involving young people in research is important and how it changed the PERFORM study.

26 May 2020

The core outcome for the PERFORM study focusses on improving the diagnosis and treatment of febrile children. PERFORM researchers, Dr Emma Lim and Prof Marieke Emonts with their team, involved young people early on in the project by joining forces with The Young Person’s Advisory Group North England (YPAGne). We talk to Dr Emma Lim and members of the YPAGne community about the unexpected turns they and the young people experienced and outcomes.

New paper published: Detailed characterisation of a new inflammatory syndrome in children related to SARS_CoV-2 & comparison to KD & TSS

9 June 2020

After all the dedicated work investigating, the PERFORM consortia along with The PIMS-TS Study Group and EUCLIDS (PERFORM's predecessor study), have published their original investigations in the paper, Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2.